US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 11.400
  • +1.470+14.80%
Close Dec 20 16:00 ET
  • 11.550
  • +0.150+1.32%
Post 20:01 ET
65.66MMarket Cap-0.45P/E (TTM)

Atara Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atara Biotherapeutics Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
35.17M
40.19M
+5.02M
Beat Est.
+1544.90%
+1779.79%
+14.28%
EPS
-20.09
-2.93
+17.16
Beat Est.
-21.77%
+82.13%
+85.42%
Analyst Rating
Buy

Dec 22, 2024

Atara Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 37.350M--
--2024/Q4-- / 33.095M--
Nov 12, 20242024/Q340.190M / 35.168M--
--2024/Q228.640M / 37.092M--
--2024/Q127.357M / 24.690M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 37.350M--
--2024/Q4-- / 33.095M--
Nov 12, 20242024/Q340.190M / 35.168M--
--2024/Q228.640M / 37.092M--
--2024/Q127.357M / 24.690M--

Unlock Free Earnings Estimates

Atara Biotherapeutics Earnings Reports

  • Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress

    Nov 12 16:42 ET

  • Atara Biotherapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:16 ET

  • Atara Biotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 17:11 ET

  • Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update

    Aug 12 17:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-0.12%